BroadSoft, Inc. (NASDAQ:BSFT) shares decreased -0.85% in last trading session and ended the day at $31.50. BSFT Gross Margin is 72.20% and its has a return on assets of -0.70%. BroadSoft, Inc. (NASDAQ:BSFT) quarterly performance is -8.77%.
BroadSoft, Inc. (NASDAQ:BSFT) and AudioCodes (Nasdaq: AUDC) announced that AudioCodes’ line of session border controllers (SBCs) and Gateways will be used by BroadSoft® for use with its BroadCloud® SIP Trunking offering, enabling Service Providers to offer the cost savings and resiliency benefits of SIP trunking to businesses that wish to maintain their legacy PBX investments. Additionally, Service Providers will benefit from interoperability and an easy-to-deploy range of SBCs and Gateways. BroadSoft and AudioCodes will jointly promote this offering, and it will be fulfilled through BroadSoft’s extensive distribution channel network.
Hill-Rom Holdings, Inc. (NYSE:HRC) ended the last trading day at $52.37. Company weekly volatility is calculated as 1.84% and price to cash ratio as 24.07. Hill-Rom Holdings, Inc. (NYSE:HRC) showed a weekly performance of 0.11%.
Hill-Rom Holdings, Inc. (NYSE:HRC) said that, it will hold its fiscal 2015 fourth quarter earnings conference call and webcast from 8:00 a.m. – 9:00 a.m. ET on the morning of Thursday, November 5, 2015.
On 21 October, Douglas Emmett Inc (NYSE:DEI) shares decreased -1.18% and was closed at $31.02. DEI EPS growth in last 5 year was 25.70%. Douglas Emmett Inc (NYSE:DEI) year to date (YTD) performance is 11.66%.
Zacks downgraded shares of Douglas Emmett Inc (NYSE:DEI) from a buy rating to a hold rating in a research report released on Wednesday morning, AnalystRatings.Net reports.
Lam Research Corporation (NASDAQ:LRCX) shares moved up 1.09% in last trading session and ended the day at $70.79. LRCX Gross Margin is 43.40% and its has a return on assets of 7.60%. Lam Research Corporation (NASDAQ:LRCX) quarterly performance is -7.70%.
Lam Research Corporation (NASDAQ:LRCX) announced financial results for the quarter ended September 27, 2015. For the September 2015 quarter, non-GAAP gross margin was $744.0 million or 46.5% of revenue, non-GAAP operating expenses were $363.6 million, non-GAAP operating margin was 23.8% of revenue, and non-GAAP net income was $313.0 million, or $1.82 per diluted share.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) caters to the Healthcare space. It has a net profit margin of 9.00% and weekly performance is -33.10%. On the last day of trading company shares ended up at $118.61. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) distance from 50-day simple moving average (SMA50) is -43.54%.
On 19 October, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) said that, it is planning for minimal price increases on its products in 2016 in the wake of two U.S. investigations into its drug pricing practices.
Leave a Reply